
Procter & Gamble Health Ltd is Rated Sell
2026-11-13 10:11:34Procter & Gamble Health Ltd is rated Sell by MarketsMOJO, with this rating last updated on 04 September 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 13 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read MoreProcter & Gamble Health Declines 2.45% Despite Quarterly Gains: 2 Key Factors Behind the Slide
2026-11-08 09:00:08Key Events This Week 2 Nov: Stock opens at ₹5,815.15, up 2.30% on strong Sensex gains 3 Nov: Reports strong quarterly turnaround with record revenue and margin gains 4 Nov: Stock declines 2.54% despite Sensex gains, signalling profit-taking 5 Nov: Technical indicators turn bearish, stock falls 1.84% 6 Nov: Bearish momentum confirmed with downgrade; stock closes at ₹5,545.00 Week Open</di...
Read More
Procter & Gamble Health Ltd is Rated Sell
2026-11-01 10:10:05Procter & Gamble Health Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 November 2026, providing investors with the latest insights into its performance and outlook.
Read MoreProcter & Gamble Health Ltd Gains 12.95%: 4 Key Factors Driving the Weekly Surge
2026-11-01 09:00:08Key Events This Week 26 Oct: Week opens at Rs.5,054.20 with a modest 0.43% gain 27 Oct: Intraday high surge of 8.71%, closing at Rs.5,524.95 (+9.31%) 28 Oct: Technical momentum shift amid mixed signals, stock dips 2.33% 29 Oct: Bearish momentum confirmed with technical downgrade, price at Rs.5,396.05 30 Oct: Mildly bearish momentum with a 3.15% gain, closing at Rs.5,684.40 Week Open</div...
Read More
Procter & Gamble Health Ltd Sees Mixed Technical Signals Amid Mild Bearish Momentum
2026-10-30 08:00:58Procter & Gamble Health Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a bearish to a mildly bearish trend. Despite a 2.12% gain on 30 Oct 2026, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages, prompting a downgrade in its Mojo Grade from Hold to Sell.
Read More
Procter & Gamble Health Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-10-29 08:00:54Procter & Gamble Health Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s recent downgrade from a Hold to a Sell rating reflects deteriorating price action and weakening market sentiment, as evidenced by multiple technical parameters across daily, weekly, and monthly timeframes.
Read More
Procter & Gamble Health Ltd Sees Technical Momentum Shift Amid Mixed Market Signals
2026-10-28 08:01:52Procter & Gamble Health Ltd has experienced a notable shift in price momentum, reflected in a 9.31% surge in its share price to ₹5,524.95 on 28 Oct 2026. Despite this strong daily gain, technical indicators present a nuanced picture, with a transition from bearish to mildly bearish trends and mixed signals across key metrics such as MACD, RSI, and moving averages. This analysis explores the implications of these technical developments for investors navigating the Pharmaceuticals & Biotechnology sector.
Read More
Procter & Gamble Health Ltd Surges 8.7% to Day's High of Rs 5529.8 — Outperforms Sector by 8.15 Percentage Points
2026-10-27 15:21:44The Sensex edged down 0.07% on 27 Oct 2026, while Procter & Gamble Health Ltd surged 8.71%, outperforming its Pharmaceuticals & Biotechnology sector by over 8 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly subdued market environment.
Read More
Procter & Gamble Health Ltd is Rated Sell
2026-10-21 10:10:02Procter & Gamble Health Ltd is rated Sell by MarketsMOJO. This rating was last updated on 04 September 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 21 October 2026, providing investors with the latest insights into the company’s performance and outlook.
Read MoreIntimation Regarding Ease Of Doing Investment - Special Window For Transfer And Dematerialization
17-Nov-2026 | Source : BSEStock Exchange is informed about an update on Ease of Investment - Special Window for Transfer and Dematerialization.
Intimation For Change In Corporate Office Address Of Registrar And Share Transfer Agent (RTA)
13-Nov-2026 | Source : BSEIntimation for Change in Corporate Office address of Registrar and Share Transfer Agent (RTA)
Outcome Of Board Meeting For The Quarter Ended September
02-Nov-2026 | Source : BSECorporate Actions
No Upcoming Board Meetings
Procter & Gamble Health Ltd has declared 450% dividend, ex-date: 27 Aug 26
No Splits history available
No Bonus history available
No Rights history available